embecta to Report Fiscal Third Quarter Financial Results
Rhea-AI Summary
embecta (Nasdaq: EMBC) will host a conference call at 8:00 a.m. ET on Friday, August 7, 2026 to discuss its fiscal third quarter 2026 financial results, provide an operational update, and hold a Q&A session. The live webcast and teleconference can be accessed via links and through the embecta investor relations website, with a replay available from 11:00 a.m. ET on August 7, 2026 and archived for one year.
Positive
- None.
Negative
- None.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 21 | 2Q26 earnings date | Neutral | +2.1% | Announced fiscal second-quarter results date and scheduled conference call for May 5. |
| Jan 22 | 1Q26 earnings date | Neutral | -9.4% | Announced fiscal first-quarter results date and scheduled conference call for February 5. |
| Nov 11 | FY25 earnings date | Neutral | +2.0% | Announced fiscal fourth-quarter and full-year results date with preliminary FY2026 guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-specific earnings-date announcements produced mixed reactions, with two positive moves and one negative move; the average move was -1.78%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 7, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 7, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |